473-51-8

Usage

InChI:InChI=1/C7H17NO8S3/c1-17(9,10)8(4-6-15-18(2,11)12)5-7-16-19(3,13)14/h4-7H2,1-3H3

Upstream product

• 124-63-0 methanesulfonyl chloride 
• 111-42-2 2,2'-iminobis[ethanol] 
• 1602-11-5 Propionsaeure- 

Downstream Products

• 1998-78-3 N,N-Bis-<2-fluor-ethyl>-methansulfonsaeureamid 
• 473-49-4 Methylsulfonsaeure- 
• 99892-20-3 (N-methyl-N',N,N'''-tritosyl)-tetraaza-1,4,7,10-cyclododecane 
• 99892-24-7 (mesyl-1-tetratosyl-4,7,10,13)-pentaaza-1,4,7,10,13-cyclopentadecane 
• 97538-25-5 1,7-Bis-methanesulfonyl-4,10-bis-(toluene-4-sulfonyl)-1,4,7,10-tetraaza-cyclododecane 
• 1396087-78-7 4-(2-((5-fluoro-6-methoxypyridin-3-yl)amino)-5-(2-(4-(methylsulfonyl)piperazin-1-yl)-propan-2-yl)pyridin-3-yl)-N,N-bis(4-methoxybenzyl)-6-methyl-1,3,5-triazin-2-amine 

Relevant academic research and scientific papers

SULFONAMIDE AND SULFINAMIDE PRODRUGS OF FUMARATES AND THEIR USE IN TREATING VARIOUS DISEASES

The present invention provides compounds and pharmaceutical compositions for treating neurological diseases such as multiple sclerosis.

THIENOPYRIMIDINES, PROCESS FOR PREPARING THE SAME AND USE THEREOF

The present invention provides a thienopyrimidine compound, represented by the formula???[wherein, R1 is C1-4 alkyl, R2 is (1) phenyl optionally having a substituent such as amino, mono C1-4 alkylamino and di C1-4 alkylamino, or (2) a heterocyclic group optionally having a substituent such as amino, mono C1-4 alkylamino and di C1-4 alkylamino and the like, R3 is a hydrogen atom or C1-4 alkyl, R4 is C1-4 alkyl optionally having a substituent such as C1-4 alkoxy-carbonyl, carboxyl, mono C1-4 alkylamino and N-C1-4 alkyl-N-C7-10 aralkylamino and the like] or a salt thereof, which has antagonistic action for gonadotropin-releasing hormone.

SYNTHESE DE COORDINATS MACROCYCLIQUES POLYAZOTES COMPORTANT UNE FONCTION AMINE SECONDAIRE DISCRIMINEE

A synthetic scheme is elaborated to prepare two polyaza-macrocycles in which one nitrogen atom is distinct from the others.Thus, (tri-N-methyl)-1,4,7,10-tetraazacyclododecane and (tetra-N-methyl)-1,4,7,10,13-pentaazacyclopentadecane were synthesised.Throu

Studies of Pendant-arm Macrocyclic Ligands. Part 1. Synthesis of Two New Penta-aza Ligands, and Observation of pH-Dependent Reversible Equilibria between Trigonal-bipyramidal and Square-planar Forms of their Nickel(II) and Copper(II) Complexes. Crystal Structure of a Trigonal-bipyrami...

Two new pendant-arm quinquedentate aza-macrocyclic ligands have been prepared, and their nickel(II) and copper(II) complexes found to undergo reversible rearrangements between approximately trigonal-bipyramidal structures at neutral pH, and protonated square-planar structures at low pH in which the pendant arms are protonated and non-co-ordinating.The crystal structure of 1>2 1 = 11-(2-dimethylaminoethyl)-1,4,7,11-tetra-azacyclotetradecane> establishes an approximately trigonal-bipyramidal geometry for the complex.Crystals are orthorhombic, space group Pna21, with a = 14.559(3), b = 15.337(3), c = 10.322(3) Angstroem, and Z = 4.The final R was 0.108 for 978 observed reflections with I/?(I) > 2.5.The axial N-Ni-N bond angle is 172(1) deg, and and the equatorial bond angles are 107(2), 107(1), and 144(2) deg.Ni-N distances range from 2.04(2) to 2.17(3) Angstroem.The nickel(II) and copper(II) complexes of L1 are isomorphous.